System and method for monitoring or treating a health condition

1 . A method for treating a health condition, comprising:

accessing a source of biological fluid;

evaluating an analyte of the biological fluid; and

administering a treatment based on the evaluation.

2 . The method of claim 1 , wherein accessing comprises making an opening in a tissue.

3 . The method of claim 2 , wherein the tissue comprises stratum corneum.

4 . The method of claim 1 , wherein the biological fluid comprises interstitial fluid, blood, serum, plasma, lymph, sweat, urine, or a combination thereof.

5 . The method of claim 4 , wherein the biological fluid comprises interstitial fluid.

6 . The method of claim 1 , wherein evaluating comprises detecting the analyte, quantitating the analyte, or a combination thereof.

7 . The method of claim 6 , wherein quantitating comprises determining an amount of analyte relative to a predetermined threshold value.

8 . The method of claim 6 , wherein quantitating comprises determining an absolute amount of analyte.

9 . The method of claim 6 , wherein detecting comprises determining that an amount of analyte is greater than a predetermined threshold value or is less than a predetermined threshold value.

10 . The method of claim 1 , wherein the treatment comprises administering a therapeutic agent or adjusting a behavior.

11 . The method of claim 10 , wherein administering the therapeutic agent comprises topical administration, oral administration, subcutaneous administration, or a combination thereof.

12 . The method of claim 11 , comprising topical administration.

13 . The method of claim 1 , wherein the analyte comprise albumin, ALP, ALT, AST, bilirubin, calcium, carbon dioxide, chloride, chlorine, creatinine, glucose, lactate, lactic acid, blood urea nitrogen, uric acid, IL-1α receptor antagonist, matrix metalloprotein-1, insulin-like growth factor-1, interleukin-1α, interleukin-2, or a combination thereof.

14 . The method of claim 1 , comprising continuous or discontinuous accessing and evaluating.

15 . The method of claim 1 , further comprising: presenting a measurement parameter.

16 . The method of claim 15 , wherein the measurement parameter comprises an amount of analyte relative to a predetermined threshold value, an absolute amount of analyte, a signal indicating an amount of analyte greater or less than a predetermined threshold value, or a combination thereof.

17 . A method for treating a health condition, comprising:

accessing a source of biological fluid;

evaluating an analyte of the biological fluid; and

presenting a measurement parameter based on the evaluation.

18 . The method of claim 17 , wherein accessing comprises making an opening in a tissue.

19 . The method of claim 18 , wherein the tissue comprises stratum corneum.

20 . The method of claim 17 , wherein the biological fluid comprises interstitial fluid, blood, serum, plasma, lymph, sweat, urine, or a combination thereof.

21 . The method of claim 20 , wherein the biological fluid comprises interstitial fluid.

22 . The method of claim 17 , wherein evaluating comprises detecting the analyte, quantitating the analyte, or a combination thereof.

23 . The method of claim 22 , wherein quantitating comprises determining an amount of analyte relative to a predetermined threshold value.

24 . The method of claim 22 , wherein quantitating comprises determining an absolute amount of analyte.

25 . The method of claim 22 , wherein detecting comprises determining that an amount of analyte is greater than a predetermined threshold value or is less than a predetermined threshold value.

26 . The method of claim 17 , wherein the measurement parameter comprises an amount of analyte relative to a predetermined threshold value, an absolute amount of analyte, a signal indicating an amount of analyte greater or less than a predetermined threshold value, or a combination thereof.

27 . The method of claim 17 , wherein presenting comprises alerting a subject or caregiver to the measurement parameter and to a need for administering a treatment.

28 . The method of claim 17 , wherein the analyte comprise albumin, ALP, ALT, AST, bilirubin, calcium, carbon dioxide, chloride, chlorine, creatinine, glucose, lactate, lactic acid, blood urea nitrogen, uric acid, IL-1α receptor antagonist, matrix metalloprotein-1, insulin-like growth factor-1, interleukin-1α, interleukin-2, or a combination thereof

29 . The method of claim 17 , comprising continuous or discontinuous accessing, evaluating, presenting, or a combination thereof

30 . The method of claim 17 , further comprising: administering a treatment based on the evaluation.

31 . The method of claim 30 , wherein the treatment comprises administering a therapeutic agent or adjusting a behavior.

32 . The method of claim 31 , wherein administering the therapeutic agent comprises topical administration, oral administration, subcutaneous administration, or a combination thereof.

33 . A system for treating a health condition, the system comprising:

a fluid handling device adapted and configured to obtain a biological fluid with an analyte and to evaluate the analyte;

a display and alert device adapted and configured to display the evaluation of the analyte and alert a user to the evaluation; and

an administration device adapted and configured to administer a therapy.

34 . The system of claim 33 , wherein the display and alert device comprises a display subdevice and an alert subdevice.

35 . The system of claim 33 , wherein the liquid handling device is adapted and configured to obtain a sample or interstitial fluid and quantitate an analyte in the interstitial fluid.